Da-Qiang Li
Overview
Explore the profile of Da-Qiang Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
4421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liao L, Zhang Y, Deng L, Chen C, Ma X, Andriani L, et al.
Cancer Res
. 2022 Dec;
83(3):471-484.
PMID: 36484700
Significance: PPP1R14B upregulation induced by RPS27A/USP9X in TNBC increases STMN1 activity, leading to cancer progression and paclitaxel resistance.
12.
Zhang F, Li D
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361605
ATP-dependent chromatin-remodeling complexes can reorganize and remodel chromatin and thereby act as important regulator in various cellular processes. Based on considerable studies over the past two decades, it has been...
13.
Yang F, Xiao Y, Ding J, Jin X, Ma D, Li D, et al.
Cell Metab
. 2022 Oct;
35(1):84-100.e8.
PMID: 36257316
Treatment of triple-negative breast cancer (TNBC) remains challenging. Deciphering the orchestration of metabolic pathways in regulating ferroptosis will provide new insights into TNBC therapeutic strategies. Here, we integrated the multiomics...
14.
Liu H, Liu Y, Zhang Y, Ning Y, Zhang F, Li D
Cell Commun Signal
. 2022 Aug;
20(1):127.
PMID: 35986334
Background: N-acetyltransferase 10 (NAT10), an abundant nucleolar protein with both lysine and RNA cytidine acetyltransferase activities, has been implicated in Hutchinson-Gilford progeria syndrome and human cancer. We and others recently...
15.
Zhang T, Liao L, Yang S, Huang M, Zhang Y, Deng L, et al.
Autophagy
. 2022 Aug;
19(3):805-821.
PMID: 35920704
Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype to treat due to the lack of effective targeted therapies. Transmembrane (TMEM) proteins represent attractive drug targets for cancer...
16.
Yang S, Xie Y, Zhang T, Deng L, Liao L, Hu S, et al.
Cancer Med
. 2022 Jul;
12(2):1602-1615.
PMID: 35796646
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, which is characterized by high heterogeneity and metabolic dysregulation. Inositol monophosphatase 1(IMPA1) is critical for the metabolism of...
17.
Yang F, Sun R, Hou Z, Zhang F, Xiao Y, Yang Y, et al.
Clin Transl Med
. 2022 May;
12(5):e825.
PMID: 35522895
Aims: MORC family CW-type zinc finger 2 (MORC2), a GHKL-type ATPase, is aberrantly upregulated in multiple types of human tumors with profound effects on cancer aggressiveness, therapeutic resistance, and clinical...
18.
Zhang Y, Deng L, Liao L, Yang S, Hu S, Ning Y, et al.
Cell Death Dis
. 2022 Apr;
13(4):408.
PMID: 35484101
Triple-negative breast cancer (TNBC) is a highly lethal disease due to aggressive clinical phenotype and the lack of validated therapeutic targets. Our recent quantitative proteomic analysis of 90 cases of...
19.
Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, et al.
Cell Metab
. 2022 Mar;
34(4):581-594.e8.
PMID: 35278352
Immunotherapy has achieved limited success in patients with triple-negative breast cancer (TNBC), an aggressive disease with a poor prognosis. Commensal microbiota have been proven to colonize the mammary gland, but...
20.
Gong T, Jiang Y, Shao C, Peng W, Liu M, Li D, et al.
Cell Rep
. 2022 Mar;
38(9):110460.
PMID: 35235781
We report a comprehensive proteomic study of a 90-case cohort of paired samples of triple-negative breast cancer (TNBC) in quantification, phosphorylation, and DNA-binding capacity. Four integrative subtypes (iP-1-4) are stratified...